Denopamine

Denopamine
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral (tablets)
ATC code	none;
Legal status
Legal status	℞-only (JP);
Identifiers
	IUPAC name 4-[(1S)-2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol;
CAS Number	71771-90-9;
PubChem CID	71754;
IUPHAR/BPS	534;
ChemSpider	64795;
UNII	V5F60UPD8P;
KEGG	D02614;
ChEMBL	ChEMBL493682;
CompTox Dashboard (EPA)	DTXSID8045800 ;
ECHA InfoCard	100.163.233
Chemical and physical data
Formula	C18H23NO4
Molar mass	317.385 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O(c1ccc(cc1OC)CCNC[C@@H](O)c2ccc(O)cc2)C;

Denopamine (INN) is a cardiotonic drug which acts as a β₁ adrenergic receptor agonist.^[1] It is used in the treatment of angina^[2] and may also have potential uses in the treatment of congestive heart failure^[3] and for clearing pulmonary oedema.^[4] It is marketed in Japan under the brand name Kalgut (カルグート) and available as tablets of 5 and 10 mg, and 5% fine granules.^[5]

References

↑ Ishide T (2002). "Denopamine, a selective beta1-receptor agonist and a new coronary vasodilator". Current Medical Research and Opinion. 18 (7): 407–13. doi:10.1185/030079902125001119. PMID 12487507. S2CID 25048757.
↑ Nakajima D, Negoro N, Nakaboh A, Nakakoji T, Hoshiga M, Nariyama J, et al. (April 2006). "Effectiveness of low dose denopamine, a beta1-adrenoceptor agonist, in a patient with vasospastic angina refractory to intensive medical treatment". International Journal of Cardiology. 108 (2): 281–3. doi:10.1016/j.ijcard.2005.03.012. PMID 15913812.
↑ Nishio R, Matsumori A, Shioi T, Wang W, Yamada T, Ono K, Sasayama S (September 1998). "Denopamine, a beta1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart". Journal of the American College of Cardiology. 32 (3): 808–15. doi:10.1016/S0735-1097(98)00314-3. hdl:2433/181223. PMID 9741531.
↑ Sakuma T, Hida M, Nambu Y, Osanai K, Toga H, Takahashi K, et al. (February 2001). "Beta1-adrenergic agonist is a potent stimulator of alveolar fluid clearance in hyperoxic rat lungs". Japanese Journal of Pharmacology. 85 (2): 161–6. doi:10.1254/jjp.85.161. PMID 11286398.
↑ "Kalgut (denopamine) Tablets 5, 10 mg; Fine granules 5%. Full Prescribing Information" (PDF) (in Japanese). Mitsubishi Tanabe Pharma Corporation. Retrieved 6 March 2016.

This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Ishide T (2002). "Denopamine, a selective beta1-receptor agonist and a new coronary vasodilator". Current Medical Research and Opinion. 18 (7): 407–13. doi:10.1185/030079902125001119. PMID 12487507. S2CID 25048757.

[2] Nakajima D, Negoro N, Nakaboh A, Nakakoji T, Hoshiga M, Nariyama J, et al. (April 2006). "Effectiveness of low dose denopamine, a beta1-adrenoceptor agonist, in a patient with vasospastic angina refractory to intensive medical treatment". International Journal of Cardiology. 108 (2): 281–3. doi:10.1016/j.ijcard.2005.03.012. PMID 15913812.

[3] Nishio R, Matsumori A, Shioi T, Wang W, Yamada T, Ono K, Sasayama S (September 1998). "Denopamine, a beta1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart". Journal of the American College of Cardiology. 32 (3): 808–15. doi:10.1016/S0735-1097(98)00314-3. hdl:2433/181223. PMID 9741531.

[4] Sakuma T, Hida M, Nambu Y, Osanai K, Toga H, Takahashi K, et al. (February 2001). "Beta1-adrenergic agonist is a potent stimulator of alveolar fluid clearance in hyperoxic rat lungs". Japanese Journal of Pharmacology. 85 (2): 161–6. doi:10.1254/jjp.85.161. PMID 11286398.

[5] "Kalgut (denopamine) Tablets 5, 10 mg; Fine granules 5%. Full Prescribing Information" (PDF) (in Japanese). Mitsubishi Tanabe Pharma Corporation. Retrieved 6 March 2016.

[1]

[2]

[3]

[4]

[5]